TY - JOUR
T1 - Effect of ATP-sensitive potassium channel agonists on ventricular remodeling in healed rat infarcts
AU - Lee, Tsung-Ming
AU - Chang, Nen Chung
PY - 2008
Y1 - 2008
N2 - Myocardial KATP channels have been implicated in the ventricular remodeling after myocardial infarction by inhibition of 70-kDa S6 (p70S6) kinase. The purpose of this study was to determine whether ATP-sensitive potassium (KATP) channel agonists exert beneficial effect on the structural, functional, and molecular features of the remodeling heart in infarcted rats. Male Wistar rats after induction of myocardial infarction were randomized to either vehicle, agonists of KATP channels nicorandil and pinacidil, an antagonist of KATP channels glibenclamide, or a combination of nicorandil and glibenclamide or pinacidil and glibenclamide for 4 weeks. To verify the role of p70S6 kinase in ventricular remodeling, rapamycin was also assessed. Significant ventricular hypertrophy was detected by increased myocyte size at the border zone isolated by enzymatic dissociation after infarction. Increased synthesis of p70S6 kinase mRNA after infarction in vehicle-treated rats was confirmed by reverse transcription-polymerase chain reaction, consistent with the results of immunohistochemistry and Western blot for p70S6 kinase. Rats in the nicorandil- and pinacidil-treated groups significantly attenuated cardiomyocyte hypertrophy and p70S6 kinase expression with similar potency, as compared with the vehicle-treated group. The beneficial effects of nicorandil and pinacidil were abolished by administering glibenclamide. Addition of rapamycin attenuated ventricular remodeling and did not have additional beneficial effects compared with rats treated with either nicorandil or pinacidil alone. Activation of KATP channels by either nicorandil or pinacidil administration can attenuate ventricular remodeling, probably through a p70S6 kinase-dependent pathway after infarction. This might provide a worthwhile therapeutic target.
AB - Myocardial KATP channels have been implicated in the ventricular remodeling after myocardial infarction by inhibition of 70-kDa S6 (p70S6) kinase. The purpose of this study was to determine whether ATP-sensitive potassium (KATP) channel agonists exert beneficial effect on the structural, functional, and molecular features of the remodeling heart in infarcted rats. Male Wistar rats after induction of myocardial infarction were randomized to either vehicle, agonists of KATP channels nicorandil and pinacidil, an antagonist of KATP channels glibenclamide, or a combination of nicorandil and glibenclamide or pinacidil and glibenclamide for 4 weeks. To verify the role of p70S6 kinase in ventricular remodeling, rapamycin was also assessed. Significant ventricular hypertrophy was detected by increased myocyte size at the border zone isolated by enzymatic dissociation after infarction. Increased synthesis of p70S6 kinase mRNA after infarction in vehicle-treated rats was confirmed by reverse transcription-polymerase chain reaction, consistent with the results of immunohistochemistry and Western blot for p70S6 kinase. Rats in the nicorandil- and pinacidil-treated groups significantly attenuated cardiomyocyte hypertrophy and p70S6 kinase expression with similar potency, as compared with the vehicle-treated group. The beneficial effects of nicorandil and pinacidil were abolished by administering glibenclamide. Addition of rapamycin attenuated ventricular remodeling and did not have additional beneficial effects compared with rats treated with either nicorandil or pinacidil alone. Activation of KATP channels by either nicorandil or pinacidil administration can attenuate ventricular remodeling, probably through a p70S6 kinase-dependent pathway after infarction. This might provide a worthwhile therapeutic target.
KW - ATP-sensitive potassium channel
KW - Hypertrophy
KW - Immunohistochemistry
KW - Myocardial infarction
KW - Remodeling
UR - http://www.scopus.com/inward/record.url?scp=43149107449&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=43149107449&partnerID=8YFLogxK
M3 - Conference article
AN - SCOPUS:43149107449
SN - 0289-8020
VL - 29
SP - 299
EP - 309
JO - Therapeutic Research
JF - Therapeutic Research
IS - 3
ER -